|
1
|
Kim TH, Rowat AC and Sloan EK: Neural
regulation of cancer: From mechanobiology to inflammation. Clin
Transl Immunology. 5:e782016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cooperative Group of Inflammatory Bowel
Diseases of Digestive Disease of Chinese Medical Association, .
Chinese consensus on standard management of inflammatory bowel
diseases (2007, Jinan). Chin J Digestion. 27:545–550. 2007.
|
|
3
|
Ye L, Cao Q and Cheng J: Review of
inflammatory bowel disease in China. Scientific World Journal.
2013.2013. 296470http://dx.doi.org/10.1155/2013/296470PubMed/NCBI
|
|
4
|
Zhao YJ and Yuan YZ: Clinical study on the
relationship between inflammatory bowel disease and colorectal
neoplasms. J Dig Dis. 10:113–117. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dhaneshwar SS: Colon-specific prodrugs of
4-aminosalicylic acid for inflammatory bowel disease. World J
Gastroenterol. 20:3564–3571. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu LC, Zhu BX, et al: Zhu Lingchun
medication experience. Publishing house of Shanghai university of
TCM; 1989
|
|
7
|
Qiu ZJ, Zhu JP and Ma XQ: Zhu Lingchun
clinical experience in the treatment of chronic colitis and
characteristic, the famous old medical liangchunzhu 19 clinical
experience in the series. Liaoning J Tradit Chin Med. 28:399–400.
2001.
|
|
8
|
Zhong LL, Ji W and Wang D: The clinical
application of XianJiTang treating of chronic diarrhea, experience
prescription of Zhu Liangchun. Jilin J Tradit Chin Med.
32:1098–1099. 2012.(In Chinese).
|
|
9
|
Chen WT, Liu X, Ren JL, et al: Based on
cluster analysis of postoperative patients with colorectal cancer
medicine research. Chin Arch Tradit Chin Med. 1:101–104. 2016.
|
|
10
|
Shin JH, Jun SL, Hwang SY and Ahn SH:
Analytical research to determine the effects of the components of
ONGABO on the viability of HepG2 cancer cells by using the
sovereign, minister, assistant and courier principle. J
Pharmacopuncture. 15:42–51. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng X: Mechanism of COX-2 controling
15-PGDH expression in gastric cancer cells (unpublished PhD
thesis)The Fourth Military Medical University; 2010
|
|
12
|
Giri S, Nath N, Smith B, Viollet B, Singh
AK and Singh I:
5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits
proinflammatory response in glial cells: A possible role of
AMP-activated protein kinase. J Neurosci. 24:479–487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hattori Y, Suzuki K, Hattori S and Kasai
K: Metformin inhibits cytokine-induced nuclear factor kappaB
activation via AMP-activated protein kinase activation in vascular
endothelial cells. Hypertension. 47:1183–1188. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang K, Deng CS, Zhu YQ and Zhang YM:
Significance of nuclear factor-NF-κB, cyclooxygenase 2 and
inducible nitric oxide synthase expression in human ulcerative
colitis tissues. World Chin J Digestology. 10:575–578. 2002.
|
|
15
|
Minami M, Shimizu K, Okamoto Y, Folco E,
Ilasaca ML, Feinberg MW, Aikawa M and Libby P: Prostaglandin E
receptor type 4-associated protein interacts directly with
NF-kappaB1 and attenuates macrophage activation. J Biol Chem.
283:9692–9703. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fulco M, Cen Y, Zhao P, Hoffman EP,
McBurney MW, Sauve AA and Sartorelli V: Glucose restriction
inhibits skeletal myoblast differentiation by activating SIRT1
through AMPK-mediated regulation of Nampt. Dev Cell. 14:661–673.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jäger S, Handschin C, St-Pierre J and
Spiegelman BM: AMP-activated protein kinase (AMPK) action in
skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl
Acad Sci USA. 104:12017–12022. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li J, Lai MD and Huang Q: Alterations of
p53 gene and microsatellite instability in ulcerative colitis and
ulcerative colitis-associated colorectal cancer. Zhejiang Da Xue
Xue Bao Yi Xue Ban. 33:108–114. 2004.(In Chinese). PubMed/NCBI
|
|
19
|
Wang H, Li Y, Zhang WW and Wang XQ: The
expression of P53, K-ras and hMSH2 in ulcerative colitis-associated
colorectal cancer. Chin J Digestion. 1:6–9. 2005.
|
|
20
|
Liu G, Park YJ, Tsuruta Y, Lorne E and
Abraham E: p53 Attenuates lipopolysaccharide-induced NF-kappaB
activation and acute lung injury. J Immunol. 182:5063–5071. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu CM, Dong WG, Yu BP, et al: Expression
of hypoxia-inducible factor-1alpha (HIF-1α) and inducible nitric
oxide synthase (iNOS) genes in inflammatory bowel disease. J The
Fourth Mil Med Univ. 17:1558–1561. 2004.
|
|
22
|
Xu L: The role of interleukin-2 and
platelet activation in the pathogenesis of ulcerative colitis
(unpublished PhD thesis)Fudan University; 2003
|
|
23
|
Qin Z, Wu C and Chen MM: Ulcerative
colitis patients of fecal calcium protein and serum interleukin-2
level and its clinical significance. Guangxi Medical Journal.
5:671–673. 2016.
|
|
24
|
Wang Y: GM-CSF and IL-1β role in the
malignant transformation of chronic enteritis and mechanism
research. The Chinese people's liberation army military academy of
medical sciences. 2014.
|
|
25
|
Wei WJ, Xu JM, Mei Q and Tang H:
Relationship between expression of transforming growth factor-β1
and its receptor in colonic mucosa with clinicopathology in
patients with ulcerative colitis. Clin J Gastroenterol. 13:341–344.
2008.
|
|
26
|
Lin Y, Cui Y, et al: Application of
particle - macrophage colony stimulating factor study curative
effect for the treatment of inflammatory bowel disease in mice.
Prog Anat Sci. 2:123–126. 2014.
|
|
27
|
Tu P, Zhang XH and Zhou XJ: Updated
correlation between angiopoietic factors and inflammatory bowel
disease. J Med Postgraduates. 20:1223–1226. 2007.
|
|
28
|
Yin W and Mei ZZ: Dual specificity
phosphatase-1: A negative regulator of inflammatory response. Int J
Immunol. 35:338–340. 2012.
|
|
29
|
Feng B, Lin ZJ and Bai H: Relationship
between anti-tumor necrosis factor-α monoclonal antibody and
chronic colitis in mice. Chin J Pract Internal Med. 26:280–282.
2006.
|
|
30
|
Song YY, Ren Y, Liu YZ, Liu W and Liu F:
Effect of Chinese medicine on tumor necrosis factor-α in treatment
of ul-cerative colitis. China Modern Doctor. 14:81–83. 2015.
|
|
31
|
Kassam Z, Belga S, Roifman I, Hirota S,
Jijon H, Kaplan GG, Ghosh S and Beck PL: Inflammatory bowel disease
cause-specific mortality: A primer for clinicians. Inflamm Bowel
Dis. 20:2483–2492. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qu N, Xu M, Mizoguchi I, Furusawa J,
Kaneko K, Watanabe K, Mizuguchi J, Itoh M, Kawakami Y and Yoshimoto
T: Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22,
and IL-23, in inflammatory diseases. Clin Dev Immunol.
2013:2013.968549 View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li XY: Alteration of the percentage of T
helper 17 lymphocytes and interleukin-6 and −17 expression in
elderly colorectal cancer patients (unpublished PhD thesis)Dalian
Medical University; 2014
|
|
34
|
Yang H: NF-κB/IL-6 pathway in relation to
the colitis associated colorectal cancer development (unpublished
PhD thesis)Zhengzhou University; 2014
|
|
35
|
Feng DM: Determination and clinical
significance of sIL-2R, IL-8 and TNF-alpha in the inflammatory
bowel disease colorectal cancer (unpublished PhD thesis)Yanbian
University; 2013
|
|
36
|
Cui Y, Liu ZJ, Zhao ZG, Zheng P-Y and
Huang D-F: Significance of interleukin-27 expression in the
intestinal mucosa of patients with inflammatory bowel disease.
World Chin J Digestology. 1:39–43. 2010. View Article : Google Scholar
|
|
37
|
Ma X, Xie Yk, Liu T, Zhang Q, Wang CH,
Zhou CJ and Gao YJ: Relative research between PAR-2 and COX-2
expressed in intestinal mucosa of patients with ulcerative colitis.
Chin J Curr Adv Gen Surg. 2:107–111. 2013.
|
|
38
|
Shi XY, Yuan W, Tang WY, et al: The
expression of G-CSF in colitis-associated cancer. Oncology
Progress. 2:168–171, 174. 2016.
|
